Literature DB >> 899065

Effect of repeated doses of ATP on serum protein pattern and fat content of the liver in experimental diabetes.

H Tahani, M Samia, S Rizk, Y A Habib, M Tallaat.   

Abstract

A comparison of serum protein fractions (electrophoretic separation) between control and mild alloxan-diabetic rats examined 10 days after alloxan indicates a decrease in total protein, a decrease in percentage albumin accompanied by a decrease in A/G ratio. In severe diabetic rats examined 48 hours after the administration of alloxan, there were no changes in total protein or in serum-protein fractions. The changes in the serum protein and serum albumin in mild diabetic cases are not the result of the degree of diabetes only. But they are rather explained by the longer time interval of the uncontrolled diabetic state. ATP administered to mild diabetic rats producing the following changes: two injections of 5 mg per rat exhibit a lowering effect on the blood glucose, with a decrease in liver fat. ATP resulted also in a significant increase in serum albumin and a decrease in beta-globulin with a consequent increase in the A/G ratio. Comparison of the different protein fractions of male and female control rats did not show any significant difference. ATP administered to control animals did not alter the normal electrophoretic pattern.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 899065     DOI: 10.1007/bf02021488

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  14 in total

Review 1.  BIOCHEMICAL PATHOLOGY OF ACUTE HEPATIC ADENOSINETRIPHOSPHATE DEFICIENCY.

Authors:  E FARBER; K H SHULL; S VILLA-TREVINO; B LOMBARDI; M THOMAS
Journal:  Nature       Date:  1964-07-04       Impact factor: 49.962

Review 2.  METABOLIC EFFECTS OF ALCOHOL ON THE LIVER.

Authors:  K J ISSELBACHER; N J GREENBERGER
Journal:  N Engl J Med       Date:  1964-02-13       Impact factor: 91.245

3.  Protein-bound carbohydrate in the serum of diabetic patients with and without vascular complications.

Authors:  N R KEIDING; E F TULLER
Journal:  Diabetes       Date:  1955 Jan-Feb       Impact factor: 9.461

4.  Protein catabolism and protein synthesis in perfused livers of normal and alloxan-diabetic rats.

Authors:  M GREEN; L L MILLER
Journal:  J Biol Chem       Date:  1960-11       Impact factor: 5.157

5.  Immediate effects of intravenous injections of tolbutamide and insulin on blood glucose and amino acids.

Authors:  R C DEMEUTTER; A K KHACHADURIAN; A MARBLE
Journal:  Proc Soc Exp Biol Med       Date:  1958-10

6.  Inhibition of muscle glucose uptake by diabetic rat sera of varying glucose and lipoprotein content.

Authors:  E D HENDLEY; E BREGMAN; M E KRAHL
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

7.  Diabetes mellitus.

Authors:  S B BEASER
Journal:  N Engl J Med       Date:  1956-07-26       Impact factor: 91.245

8.  Alloxan diabetes and phosphate turnover in the liver.

Authors:  J Sacks
Journal:  Am J Physiol       Date:  1953-01

9.  Biochemical aspects associated with an ethanol-induced fatty liver.

Authors:  J E Walker; E R Gordon
Journal:  Biochem J       Date:  1970-09       Impact factor: 3.857

10.  Serum lipoprotein accumulation in the livers of orotic acid-fed rats.

Authors:  L A Pottenger; G S Getz
Journal:  J Lipid Res       Date:  1971-07       Impact factor: 5.922

View more
  3 in total

Review 1.  ATP Secretion and Metabolism in Regulating Pancreatic Beta Cell Functions and Hepatic Glycolipid Metabolism.

Authors:  Jing Li; Han Yan; Rui Xiang; Weili Yang; Jingjing Ye; Ruili Yin; Jichun Yang; Yujing Chi
Journal:  Front Physiol       Date:  2022-06-21       Impact factor: 4.755

Review 2.  Purinergic signalling in the liver in health and disease.

Authors:  Geoffrey Burnstock; Byron Vaughn; Simon C Robson
Journal:  Purinergic Signal       Date:  2013-11-24       Impact factor: 3.765

Review 3.  Purinergic signalling and diabetes.

Authors:  Geoffrey Burnstock; Ivana Novak
Journal:  Purinergic Signal       Date:  2013-04-03       Impact factor: 3.765

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.